activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650018	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1650018	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4597	Homo sapiens	Kd		
	1650019	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
Not Active	1650020	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4597	Homo sapiens	Kd		
	1650021	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	130.0	CHEMBL4597	Homo sapiens	Kd	uM	0.13
	1650022	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2400.0	CHEMBL4597	Homo sapiens	Kd	uM	2.4
	1650023	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	8000.0	CHEMBL4597	Homo sapiens	Kd	uM	8.0
Not Active	1650024	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4597	Homo sapiens	Kd		
	1650025	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	990.0	CHEMBL4597	Homo sapiens	Kd	uM	0.99
	1650026	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	180.0	CHEMBL4597	Homo sapiens	Kd	uM	0.18
	1651995	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	25.0	CHEMBL4597	Homo sapiens	Kd	uM	0.025
Not Active	1651996	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1651997	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1651998	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1651999	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4597	Homo sapiens	Kd		
	1652000	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	180.0	CHEMBL4597	Homo sapiens	Kd	uM	0.18
Not Active	1652001	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1652002	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1652003	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1652004	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL4597	Homo sapiens	Kd		
Not Active	1652005	CHEMBL860663	Average Binding Constant for PCTK1; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4597	Homo sapiens	Kd		
	2206858	CHEMBL990533	Inhibition of PCTK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	130.0	CHEMBL4597	Homo sapiens	Kd	nM	130.0
	2470309	CHEMBL992486	Inhibition of PCTK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4597	Homo sapiens	INH	%	10.0
Not Evaluated	2476746	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2478585	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4597	Homo sapiens	Activity		
Active	2478788	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4597	Homo sapiens	Activity		
	2479643	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	1.2	CHEMBL4597	Homo sapiens	Activity	%	1.2
	2479846	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	16.4	CHEMBL4597	Homo sapiens	Activity	%	16.4
Active	2480643	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4597	Homo sapiens	Activity		
	2480845	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.2	CHEMBL4597	Homo sapiens	Activity	%	0.2
	2577264	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	2.4	CHEMBL4597	Homo sapiens	Activity	%	2.4
Active	2577467	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2593672	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2593938	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2594141	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2594881	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2595084	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2596281	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4597	Homo sapiens	Activity		
Active	2596484	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4597	Homo sapiens	Activity		
Not Evaluated	2597753	CHEMBL982774	Binding affinity to human PCTAIRE1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4597	Homo sapiens	Activity		
	2898212	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898213	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898214	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	420.0	CHEMBL4597	Homo sapiens	Kd	nM	420.0
	2898215	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	6300.0	CHEMBL4597	Homo sapiens	Kd	nM	6300.0
	2898216	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898217	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	7.1	CHEMBL4597	Homo sapiens	Kd	nM	7.1
	2898218	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	430.0	CHEMBL4597	Homo sapiens	Kd	nM	430.0
	2898219	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898220	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898221	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898222	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898223	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898224	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898225	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898226	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	440.0	CHEMBL4597	Homo sapiens	Kd	nM	440.0
	2898227	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898228	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898229	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1200.0	CHEMBL4597	Homo sapiens	Kd	nM	1200.0
	2898230	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898231	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	23.0	CHEMBL4597	Homo sapiens	Kd	nM	23.0
	2898232	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898233	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898234	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	6000.0	CHEMBL4597	Homo sapiens	Kd	nM	6000.0
	2898235	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898236	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898237	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898238	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898239	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898240	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898241	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898242	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898243	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2898244	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	24.0	CHEMBL4597	Homo sapiens	Kd	nM	24.0
	2898245	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	940.0	CHEMBL4597	Homo sapiens	Kd	nM	940.0
	2898246	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	150.0	CHEMBL4597	Homo sapiens	Kd	nM	150.0
	2898247	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	230.0	CHEMBL4597	Homo sapiens	Kd	nM	230.0
	2899023	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2899024	CHEMBL1051303	Binding constant for PCTK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	2921228	CHEMBL1057575	Inhibition of PCTK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	98.0	CHEMBL4597	Homo sapiens	Activity	%	98.0
	3052435	CHEMBL1070470	Residual activity of PCTAIRE1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	76.0	CHEMBL4597	Homo sapiens	Residual activity	%	76.0
	3052687	CHEMBL1041174	Residual activity of PCTAIRE1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	86.0	CHEMBL4597	Homo sapiens	Residual activity	%	86.0
	3053996	CHEMBL1050327	Residual activity of PCTAIRE1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	153.0	CHEMBL4597	Homo sapiens	Residual activity	%	153.0
	3054248	CHEMBL1070470	Residual activity of PCTAIRE1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	78.0	CHEMBL4597	Homo sapiens	Residual activity	%	78.0
	3055535	CHEMBL1041174	Residual activity of PCTAIRE1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	88.0	CHEMBL4597	Homo sapiens	Residual activity	%	88.0
	3056840	CHEMBL1050327	Residual activity of PCTAIRE1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	163.0	CHEMBL4597	Homo sapiens	Residual activity	%	163.0
	3057092	CHEMBL1070470	Residual activity of PCTAIRE1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	83.0	CHEMBL4597	Homo sapiens	Residual activity	%	83.0
	3058412	CHEMBL1041174	Residual activity of PCTAIRE1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	81.0	CHEMBL4597	Homo sapiens	Residual activity	%	81.0
	3059696	CHEMBL1050327	Residual activity of PCTAIRE1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	126.0	CHEMBL4597	Homo sapiens	Residual activity	%	126.0
	3062495	CHEMBL1037982	Binding affinity to human PCTK1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	94.0	CHEMBL4597	Homo sapiens	Activity	%	94.0
	3063630	CHEMBL1074896	Binding affinity to human PCTK1 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	75.0	CHEMBL4597	Homo sapiens	Activity	%	75.0
	3063720	CHEMBL1042482	Binding affinity to human PCTK1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	98.0	CHEMBL4597	Homo sapiens	Activity	%	98.0
	3066875	CHEMBL1066081	Inhibition of PCTK1 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4597	Homo sapiens	INH	%	0.0
	3066965	CHEMBL1066081	Inhibition of PCTK1 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	40.0	CHEMBL4597	Homo sapiens	INH	%	40.0
	3203254	CHEMBL1102990	Inhibition of PCTK1	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	12.0	CHEMBL4597	Homo sapiens	Kd	uM	0.012
	3332071	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3333486	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3334891	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3336311	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3337607	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3338938	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3339192	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3340495	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3341853	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3343300	CHEMBL1166609	Inhibition of PCTK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4597	Homo sapiens	INH	%	50.0
	3358719	CHEMBL1175185	Inhibition of PCTK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	8.4	CHEMBL4597	Homo sapiens	INH	%	8.4
	3359161	CHEMBL1175185	Inhibition of PCTK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	46.0	CHEMBL4597	Homo sapiens	INH	%	46.0
	3445234	CHEMBL1244555	Binding affinity to PCTK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	27.0	CHEMBL4597	Homo sapiens	Kd	nM	27.0
	3448867	CHEMBL1244555	Binding affinity to PCTK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	6000.0	CHEMBL4597	Homo sapiens	Kd	nM	6000.0
	3449295	CHEMBL1244555	Binding affinity to PCTK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	150.0	CHEMBL4597	Homo sapiens	Kd	nM	150.0
	3449777	CHEMBL1244555	Binding affinity to PCTK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	3450175	CHEMBL1244555	Binding affinity to PCTK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	3450833	CHEMBL1244555	Binding affinity to PCTK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	3451095	CHEMBL1244555	Binding affinity to PCTK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	uM	10.0
	6339887	CHEMBL1826086	Activity of PCTK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	41.0	CHEMBL4597	Homo sapiens	Activity	%	41.0
	7567431	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7567919	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	2300.0	CHEMBL4597	Homo sapiens	Kd	nM	2300.0
	7568387	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7568819	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	940.0	CHEMBL4597	Homo sapiens	Kd	nM	940.0
	7569422	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7569894	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7570357	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1100.0	CHEMBL4597	Homo sapiens	Kd	nM	1100.0
	7570784	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	150.0	CHEMBL4597	Homo sapiens	Kd	nM	150.0
	7570938	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7571395	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7571871	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7572334	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7572750	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	560.0	CHEMBL4597	Homo sapiens	Kd	nM	560.0
	7572919	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7573376	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7573852	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7574321	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7574729	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7574897	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	21.0	CHEMBL4597	Homo sapiens	Kd	nM	21.0
	7575358	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7575829	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7576871	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7577330	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	890.0	CHEMBL4597	Homo sapiens	Kd	nM	890.0
	7577808	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	830.0	CHEMBL4597	Homo sapiens	Kd	nM	830.0
	7577836	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7578241	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	3100.0	CHEMBL4597	Homo sapiens	Kd	nM	3100.0
	7578879	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1500.0	CHEMBL4597	Homo sapiens	Kd	nM	1500.0
	7579253	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7579703	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	440.0	CHEMBL4597	Homo sapiens	Kd	nM	440.0
	7580204	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7580607	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7581237	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7581622	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	890.0	CHEMBL4597	Homo sapiens	Kd	nM	890.0
	7582096	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7582560	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7582960	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	230.0	CHEMBL4597	Homo sapiens	Kd	nM	230.0
	7583583	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2800.0	CHEMBL4597	Homo sapiens	Kd	nM	2800.0
	7583980	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	7.1	CHEMBL4597	Homo sapiens	Kd	nM	7.1
	7583983	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7584454	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	5300.0	CHEMBL4597	Homo sapiens	Kd	nM	5300.0
	7584916	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7585320	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7586325	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	1100.0	CHEMBL4597	Homo sapiens	Kd	nM	1100.0
	7586796	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2600.0	CHEMBL4597	Homo sapiens	Kd	nM	2600.0
	7587250	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	0.54	CHEMBL4597	Homo sapiens	Kd	nM	0.54
	7587432	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7587851	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7588304	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7588775	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7589226	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7589397	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	5300.0	CHEMBL4597	Homo sapiens	Kd	nM	5300.0
	7589821	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	27.0	CHEMBL4597	Homo sapiens	Kd	nM	27.0
	7590288	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7590762	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	6000.0	CHEMBL4597	Homo sapiens	Kd	nM	6000.0
	7591213	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7591370	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7591792	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	430.0	CHEMBL4597	Homo sapiens	Kd	nM	430.0
	7592264	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7592737	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7593337	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	420.0	CHEMBL4597	Homo sapiens	Kd	nM	420.0
	7593772	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7594244	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7594727	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	2400.0	CHEMBL4597	Homo sapiens	Kd	nM	2400.0
	7595305	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	1.1	CHEMBL4597	Homo sapiens	Kd	nM	1.1
	7595749	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7596223	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7596252	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7596699	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7597277	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	6300.0	CHEMBL4597	Homo sapiens	Kd	nM	6300.0
	7597730	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4597	Homo sapiens	Kd	nM	10000.0
	7598231	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1200.0	CHEMBL4597	Homo sapiens	Kd	nM	1200.0
	7598673	CHEMBL1908730	Binding constant for PCTK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	24.0	CHEMBL4597	Homo sapiens	Kd	nM	24.0
	8046130	CHEMBL1959377	Inhibition of PCTK1 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	99.0	CHEMBL4597	Homo sapiens	INH	%	99.0
	12172298	CHEMBL2215413	Inhibition of PCTK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	13414694	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414695	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414696	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414697	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414698	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414699	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414700	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414701	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414702	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414703	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414704	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414705	CHEMBL2424031	Inhibition of PCTAIRE1 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	71.1	CHEMBL4597	Homo sapiens	INH	%	71.1
	13414898	CHEMBL2424251	Inhibition of PCTAIRE1 in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O[C@H]1CC[C@H](Nc2nc3ccccc3n3ccnc23)CC1		CHEMBL2420582	=	Inhibition	%	38.9	CHEMBL4597	Homo sapiens	INH	%	38.9
	13414899	CHEMBL2424251	Inhibition of PCTAIRE1 in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	c1ccc(CNc2nc3ccccc3n3ccnc23)cc1		CHEMBL2420578	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414900	CHEMBL2424251	Inhibition of PCTAIRE1 in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	c1ccc(CCNc2nc3ccccc3n3ccnc23)cc1		CHEMBL2420577	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13414901	CHEMBL2424251	Inhibition of PCTAIRE1 in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	c1ccc2c(c1)nc(NC1CCCCC1)c1nccn12		CHEMBL2420576	<	Inhibition	%	35.0	CHEMBL4597	Homo sapiens	INH	%	35.0
	13442320	CHEMBL2429488	Competitive binding affinity to PCTK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	99.0	CHEMBL4597	Homo sapiens	INH	%	99.0
	13445455	CHEMBL2429488	Competitive binding affinity to PCTK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL4597	Homo sapiens	INH	%	100.0
	13448510	CHEMBL2429488	Competitive binding affinity to PCTK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	99.0	CHEMBL4597	Homo sapiens	INH	%	99.0
	13448646	CHEMBL2429488	Competitive binding affinity to PCTK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	91.0	CHEMBL4597	Homo sapiens	INH	%	91.0
	13451441	CHEMBL2429488	Competitive binding affinity to PCTK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	100.0	CHEMBL4597	Homo sapiens	INH	%	100.0
	13454626	CHEMBL2429488	Competitive binding affinity to PCTK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL4597	Homo sapiens	INH	%	100.0
	15258366	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	3.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.5
	15258426	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15258486	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15258546	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	1.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.4
	15258606	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15258666	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	-1.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-1.4
	15258726	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.6
	15258786	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-1.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-1.2
	15258846	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	3.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.2
	15258906	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	3.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.1
	15258966	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259026	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	5.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	5.8
	15259086	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	8.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	8.7
	15259146	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	8.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	8.9
	15259206	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	10.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	10.0
	15259266	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	1.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.9
	15259326	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	1.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.1
	15259386	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.2
	15259446	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.3
	15259506	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.4
	15259566	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.5
	15259626	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.6
	15259686	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	1.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.4
	15259746	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259806	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259866	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	-1.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-1.4
	15259926	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15259986	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15260046	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260106	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.2
	15260166	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	-0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.3
	15260226	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15260286	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	3.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.9
	15260346	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15260406	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260466	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.9
	15260526	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	3.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.9
	15260586	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	3.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.2
	15260646	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.4
	15260706	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	8.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	8.1
	15260766	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.5
	15260826	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	4.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	4.1
	15260886	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	1.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.4
	15260946	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261006	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.2
	15261066	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	7.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	7.7
	15261126	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	-0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261209	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	-0.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.9
	15261269	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15261329	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15261389	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	-1.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-1.0
	15261444	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	0.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.0
	15261504	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261564	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	0.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.8
	15261624	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261697	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	-0.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.9
	15261757	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	-0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.7
	15261817	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	1.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.2
	15261877	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15261933	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.0
	15261993	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262053	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.3
	15262113	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	0.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.9
	15262186	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262246	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15262306	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15262366	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15262426	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	-0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.3
	15262486	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.0
	15262546	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262606	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15262666	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	-0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.3
	15262726	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262786	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15262846	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15262906	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15262966	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.3
	15263026	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	2.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	2.0
	15263086	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	3.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.8
	15263146	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	-0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.7
	15263206	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15263266	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15263326	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15263422	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	-1.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-1.7
	15263477	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	-1.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-1.1
	15263537	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15263597	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	2.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	2.0
	15263657	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15263717	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15263731	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	-0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.7
	15263791	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15263851	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15263911	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	-0.5	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.5
	15263971	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264025	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15264085	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15264145	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264205	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264278	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	4.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	4.7
	15264338	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264398	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.7
	15264458	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15264514	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	3.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.2
	15264574	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	0.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.8
	15264634	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15264694	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264766	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	2.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	2.2
	15264826	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	4.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	4.4
	15264886	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	0.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.0
	15264946	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	0.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.8
	15265002	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	-0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.7
	15265062	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	3.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.1
	15265122	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	-0.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.8
	15265182	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	2.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	2.3
	15265255	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15265315	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15265375	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265435	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	-0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265491	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.7
	15265551	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.3
	15265611	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265671	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.2
	15265743	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265803	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265863	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265923	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265980	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15266040	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.0
	15266100	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.0
	15266160	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	5.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	5.6
	15266232	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.1
	15266292	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.4
	15266352	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.8
	15266412	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	1.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.7
	15266467	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	5.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	5.9
	15266527	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	2.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	2.1
	15266587	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	3.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.0
	15266647	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	4.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	4.7
	15266720	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	1.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.8
	15266780	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	-0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.7
	15266840	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	3.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.3
	15266900	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	-0.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.7
	15266955	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	1.7	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	1.7
	15267015	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	5.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	5.3
	15267075	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	2.9	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	2.9
	15267135	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	3.0	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	3.0
	15267195	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	6.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	6.8
	15267208	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	-0.1	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267268	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	-0.2	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267328	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	-0.6	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.6
	15267388	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15267448	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.8	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.8
	15267503	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15267563	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	0.4
	15267623	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-0.3	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267683	CHEMBL3430825	Delta TM value showing the stabilisation of PCTK1 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.4	CHEMBL4597	Homo sapiens	Thermal melting change	degrees C	-0.4
	15755911	CHEMBL3631431	Inhibition of PCTK1 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	92.0	CHEMBL4597	Homo sapiens	Activity	%	92.0
	16486370	CHEMBL3771604	Inhibition of human recombinant PCTK1 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
Not Active	16514155	CHEMBL3782376	Inhibition of partial length human PCTK1 expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4597	Homo sapiens	INH		
	16594859	CHEMBL3812878	Inhibition of human PCTK1 (160 to 474 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
335747	17713965	CHEMBL3887395	LanthaScreen TR-FRET Assay: Compound 1 was also assayed to determine the IC50 values for three different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The assay was conducted with the same method described below in the second assay. Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266). In a first screening assay, compounds were tested in duplicate at a concentration of 10 M.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22 C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um).	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccc(O)cc4)CC3)c2c1		CHEMBL3736216	=	IC50	nM	1500.0	CHEMBL4597	Homo sapiens	IC50	nM	1500.0
335748	17713966	CHEMBL3887395	LanthaScreen TR-FRET Assay: Compound 1 was also assayed to determine the IC50 values for three different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The assay was conducted with the same method described below in the second assay. Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266). In a first screening assay, compounds were tested in duplicate at a concentration of 10 M.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22 C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um).	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccc(O)cc4)CC3)c2c1		CHEMBL3736216	=	IC50	nM	2900.0	CHEMBL4597	Homo sapiens	IC50	nM	2900.0
Inactive	17889223	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889224	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889225	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889226	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889227	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889228	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889229	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889230	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889231	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	1055.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1055.0
Active	17889232	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	35.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	35.0
Inactive	17889233	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889234	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889235	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889236	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889237	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889238	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889239	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889240	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889241	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889242	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	50.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	50.0
Inactive	17889243	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889244	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889245	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889246	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889247	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889248	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889249	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889250	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889251	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889252	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889253	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889254	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889255	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889256	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889257	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889258	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889259	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889260	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17889261	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2353.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	2353.0
Inactive	17889262	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889263	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889264	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	1162.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1162.0
Inactive	17889265	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889266	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889267	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889268	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889269	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889270	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889271	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889272	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889273	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889274	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889275	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889276	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889277	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889278	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889279	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889280	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889281	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889282	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889283	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889284	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889285	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889286	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889287	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889288	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889289	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889290	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889291	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17889292	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	36.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	36.0
Inactive	17889293	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889294	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889295	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889296	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889297	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	8.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	8.0
Inactive	17889298	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889299	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889300	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889301	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3714.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	3714.0
Inactive	17889302	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889303	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889304	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889305	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889306	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889307	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889308	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889309	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889310	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889311	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Kd	nM	2778.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	2778.0
Inactive	17889312	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889313	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889314	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889315	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	3097.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	3097.0
Inactive	17889316	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889317	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	1213.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1213.0
Inactive	17889318	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889319	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889320	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889321	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889322	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889323	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889324	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889325	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889326	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	113.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	113.0
Inactive	17889327	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889328	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889329	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889330	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889331	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889332	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889333	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889334	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889335	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	526.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	526.0
Inactive	17889336	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889337	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889338	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889339	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	=	Kd	nM	2668.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	2668.0
Inactive	17889340	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889341	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889342	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889343	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889344	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889345	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889346	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889347	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889348	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889349	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889350	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889351	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889352	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	=	Kd	nM	3762.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	3762.0
Uncertain	17889353	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	=	Kd	nM	3845.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	3845.0
Active	17889354	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	1096.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1096.0
Inactive	17889355	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889356	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889357	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889358	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	314.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	314.0
Inactive	17889359	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889360	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889361	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889362	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889363	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889364	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889365	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889366	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889367	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889368	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889369	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889370	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889371	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	1994.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1994.0
Inactive	17889372	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889373	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889374	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889375	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889376	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889377	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889378	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889379	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889380	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889381	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889382	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889383	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889384	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889385	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	444.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	444.0
Inactive	17889386	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889387	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889388	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889389	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889390	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889391	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889392	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1092.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1092.0
Inactive	17889393	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889394	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889395	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889396	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889397	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889398	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889399	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889400	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889401	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889402	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889403	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889404	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889405	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889406	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889407	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889408	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889409	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889410	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889411	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889412	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	34.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	34.0
Inactive	17889413	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889414	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889415	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889416	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889417	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	3.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	3.0
Active	17889418	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	13.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	13.0
Inactive	17889419	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889420	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889421	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	3387.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	3387.0
Inactive	17889422	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889423	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889424	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889425	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889426	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889427	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889428	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889429	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889430	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889431	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1729.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	1729.0
Inactive	17889432	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889433	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889434	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889435	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889436	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889437	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889438	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889439	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889440	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	Kd	nM	125.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	125.0
Inactive	17889441	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889442	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889443	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889444	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889445	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Active	17889446	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	32.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	32.0
Inactive	17889447	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889448	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889449	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889450	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889451	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889452	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889453	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889454	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889455	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889456	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889457	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889458	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889459	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889460	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889461	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889462	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889463	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889464	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17889465	CHEMBL3991654	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4597	Homo sapiens	Kd apparent	nM	30000.0
	17964932	CHEMBL3995041	Inhibition of human PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	18114202	CHEMBL4025292	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL4597	Homo sapiens	Activity	%	99.0
	18153049	CHEMBL4034445	Inhibition of PCTAIRE1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	21.4	CHEMBL4597	Homo sapiens	INH	%	21.4
	18153249	CHEMBL4034446	Inhibition of PCTAIRE1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	17.2	CHEMBL4597	Homo sapiens	INH	%	17.2
	18203816	CHEMBL4044103	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	18211578	CHEMBL4045792	Inhibition of PCTAIRE1 conserved Lys2 (DLKPQNLLINER) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-14.6	CHEMBL4597	Homo sapiens	INH	%	-14.6
	18211937	CHEMBL4046033	Inhibition of PCTAIRE1 conserved Lys2 (DLKPQNLLINER) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-6.4	CHEMBL4597	Homo sapiens	INH	%	-6.4
	18253897	CHEMBL4055233	Inhibition of wild-type human partial length PCTAIRE1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	18253898	CHEMBL4055233	Inhibition of wild-type human partial length PCTAIRE1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	89.0	CHEMBL4597	Homo sapiens	Activity	%	89.0
	18275187	CHEMBL4118441	Inhibition of PCTAIRE1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SKLTDNLVALKEIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-8.0	CHEMBL4597	Homo sapiens	INH	%	-8.0
	18275188	CHEMBL4118441	Inhibition of PCTAIRE1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SKLTDNLVALKEIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-5.2	CHEMBL4597	Homo sapiens	INH	%	-5.2
	18275189	CHEMBL4118441	Inhibition of PCTAIRE1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled SKLTDNLVALKEIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-18.8	CHEMBL4597	Homo sapiens	INH	%	-18.8
	18275190	CHEMBL4118442	Inhibition of PCTAIRE1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPQNLLINER probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-3.2	CHEMBL4597	Homo sapiens	INH	%	-3.2
	18275191	CHEMBL4118442	Inhibition of PCTAIRE1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPQNLLINER probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-5.9	CHEMBL4597	Homo sapiens	INH	%	-5.9
	18275192	CHEMBL4118442	Inhibition of PCTAIRE1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPQNLLINER probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	-6.3	CHEMBL4597	Homo sapiens	INH	%	-6.3
	18420785	CHEMBL4153884	Inhibition of CDK16 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3cc2c1		CHEMBL4163273	=	Inhibition	%	-1.0	CHEMBL4597	Homo sapiens	INH	%	-1.0
	18420786	CHEMBL4153884	Inhibition of CDK16 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	CN1CCN(Cc2ccc(CNc3nc4nc5ccc(Cl)cc5cc4c(=O)[nH]3)cc2)CC1		CHEMBL4171176	=	Inhibition	%	11.0	CHEMBL4597	Homo sapiens	INH	%	11.0
	18420787	CHEMBL4153884	Inhibition of CDK16 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	O=c1[nH]c(NCc2ccc(CN3CCCCC3)cc2)nc2nc3ccccc3cc12		CHEMBL4160278	=	Inhibition	%	-5.0	CHEMBL4597	Homo sapiens	INH	%	-5.0
	18420788	CHEMBL4153884	Inhibition of CDK16 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3nc2c1		CHEMBL4171939	=	Inhibition	%	12.0	CHEMBL4597	Homo sapiens	INH	%	12.0
	18420789	CHEMBL4153884	Inhibition of CDK16 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc(CCN2CCC(Nc3nc4nc5ccc(C)cc5nc4c(=O)[nH]3)CC2)cc1		CHEMBL4167512	=	Inhibition	%	18.0	CHEMBL4597	Homo sapiens	INH	%	18.0
	18420790	CHEMBL4153884	Inhibition of CDK16 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	10.0	CHEMBL4597	Homo sapiens	INH	%	10.0
	18440358	CHEMBL4157182	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	95.0	CHEMBL4597	Homo sapiens	Activity	%	95.0
	18484314	CHEMBL4185961	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	18484798	CHEMBL4185961	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	74.0	CHEMBL4597	Homo sapiens	Activity	%	74.0
	18489544	CHEMBL4187285	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	59.0	CHEMBL4597	Homo sapiens	Activity	%	59.0
	18655374	CHEMBL4230861	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	18663940	CHEMBL4232924	Inhibition of human PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	95.0	CHEMBL4597	Homo sapiens	Activity	%	95.0
	18664037	CHEMBL4233021	Binding affinity to human PCTK1 (G160 to A474 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4597	Homo sapiens	Kd	uM	5.0
	18697667	CHEMBL4254340	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	66.0	CHEMBL4597	Homo sapiens	Activity	%	66.0
	18752113	CHEMBL4264450	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	46.0	CHEMBL4597	Homo sapiens	Activity	%	46.0
Not Active	18847287	CHEMBL4304933	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4597	Homo sapiens	INH		
	18858114	CHEMBL4307960	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	92.0	CHEMBL4597	Homo sapiens	Activity	%	92.0
	18958646	CHEMBL4333545	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	19059738	CHEMBL4358039	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4597	Homo sapiens	Activity	%	100.0
	19090303	CHEMBL4365877	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	81.0	CHEMBL4597	Homo sapiens	Activity	%	81.0
	19159566	CHEMBL4382670	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	91.0	CHEMBL4597	Homo sapiens	Activity	%	91.0
	19191441	CHEMBL4389389	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	70.0	CHEMBL4597	Homo sapiens	INH	%	70.0
	19192052	CHEMBL4389866	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	80.0	CHEMBL4597	Homo sapiens	INH	%	80.0
	19200308	CHEMBL4391492	Binding affinity to wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	4.3	CHEMBL4597	Homo sapiens	Activity	%	4.3
	19452705	CHEMBL4434180	Inhibition of CDK16 in human HCT116 cells at 1 uM incubated for 4 hrs by KINATIV live cell profiling protocol based assay	B	CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cc(Cl)cc3Cl)CC2)c1.O=C(O)C(F)(F)F		CHEMBL4434727	>	Inhibition	%	90.0	CHEMBL4597	Homo sapiens	INH	%	90.0
	19452716	CHEMBL4434180	Inhibition of CDK16 in human HCT116 cells at 1 uM incubated for 4 hrs by KINATIV live cell profiling protocol based assay	B	COc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCN(S(=O)(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)CC1.O=C(O)C(F)(F)F		CHEMBL4542127	<	Inhibition	%	90.0	CHEMBL4597	Homo sapiens	INH	%	90.0
	19452717	CHEMBL4434180	Inhibition of CDK16 in human HCT116 cells at 1 uM incubated for 4 hrs by KINATIV live cell profiling protocol based assay	B	CN(C)C/C=C/C(=O)Nc1cccc(CN2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)CC2)c1.O=C(O)C(F)(F)F		CHEMBL4534124	>	Inhibition	%	90.0	CHEMBL4597	Homo sapiens	INH	%	90.0
	19452718	CHEMBL4434180	Inhibition of CDK16 in human HCT116 cells at 1 uM incubated for 4 hrs by KINATIV live cell profiling protocol based assay	B	CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)CC2)c1.O=C(O)C(F)(F)F		CHEMBL4522598	>	Inhibition	%	90.0	CHEMBL4597	Homo sapiens	INH	%	90.0
	22475895	CHEMBL4686320	Inhibition of human CDK16 incubated for 30 mins by Kinobead based assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3oc(C(=O)c4cc5cc(O)ccc5[nH]4)cc3c2)no1		CHEMBL4745937	=	EC50	nM	1768.0	CHEMBL4597	Homo sapiens	EC50	nM	1768.0
Not Active	22889541	CHEMBL4729060	Inhibition of wild-type human partial length PCTK1 (G160 to A474 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4597	Homo sapiens	INH		
	23122372	CHEMBL4804751	Inhibition of PCTAIRE1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-15600.0	CHEMBL4597	Homo sapiens	IC50	uM	-15.6
	23122373	CHEMBL4804751	Inhibition of PCTAIRE1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-200.0	CHEMBL4597	Homo sapiens	IC50	uM	-0.2
	23122374	CHEMBL4804751	Inhibition of PCTAIRE1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	9000.0	CHEMBL4597	Homo sapiens	IC50	uM	9.0
	23122375	CHEMBL4804752	Inhibition of PCTAIRE1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4597	Homo sapiens	INH	%	0.0
	23122376	CHEMBL4804752	Inhibition of PCTAIRE1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4597	Homo sapiens	INH	%	0.0
	23122377	CHEMBL4804752	Inhibition of PCTAIRE1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4597	Homo sapiens	INH	%	0.0
	23122723	CHEMBL4805074	Inhibition of human PCTK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	68.0	CHEMBL4597	Homo sapiens	Activity	%	68.0
	23123418	CHEMBL4805662	Inhibition of human PCTK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	43.0	CHEMBL4597	Homo sapiens	Activity	%	43.0
	23123875	CHEMBL4806119	Inhibition of DNA-tagged human PCTK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	92.0	CHEMBL4597	Homo sapiens	Activity	%	92.0
	23124926	CHEMBL4806679	Inhibition of human PCTK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL4597	Homo sapiens	Activity	%	92.0
	23124927	CHEMBL4806679	Inhibition of human PCTK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	64.0	CHEMBL4597	Homo sapiens	Activity	%	64.0
Not Active	23317559	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	86.0	CHEMBL4597	Homo sapiens	% Control	%	86.0
Not Active	23318027	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23318693	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23319177	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	85.0	CHEMBL4597	Homo sapiens	% Control	%	85.0
Not Active	23319814	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	74.8	CHEMBL4597	Homo sapiens	% Control	%	74.8
Not Active	23320289	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23320967	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23321435	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	81.0	CHEMBL4597	Homo sapiens	% Control	%	81.0
Not Active	23322065	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	77.0	CHEMBL4597	Homo sapiens	% Control	%	77.0
Not Active	23322533	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	89.0	CHEMBL4597	Homo sapiens	% Control	%	89.0
Not Active	23323222	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	88.0	CHEMBL4597	Homo sapiens	% Control	%	88.0
Not Active	23323690	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23324544	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	88.9	CHEMBL4597	Homo sapiens	% Control	%	88.9
Not Active	23325179	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	98.0	CHEMBL4597	Homo sapiens	% Control	%	98.0
Not Active	23325647	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23326294	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	92.0	CHEMBL4597	Homo sapiens	% Control	%	92.0
Not Active	23326762	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23327462	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23327930	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	80.0	CHEMBL4597	Homo sapiens	% Control	%	80.0
Not Active	23328517	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23328985	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23329931	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23330399	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23331155	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23331623	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23332210	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	92.5	CHEMBL4597	Homo sapiens	% Control	%	92.5
Not Active	23332676	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23333394	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23334033	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	87.0	CHEMBL4597	Homo sapiens	% Control	%	87.0
Not Active	23334501	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	83.0	CHEMBL4597	Homo sapiens	% Control	%	83.0
Not Active	23335480	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL4597	Homo sapiens	% Control	%	99.0
Not Active	23335948	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23336575	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23337043	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	78.0	CHEMBL4597	Homo sapiens	% Control	%	78.0
Not Active	23338124	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	86.0	CHEMBL4597	Homo sapiens	% Control	%	86.0
Not Active	23338592	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	80.0	CHEMBL4597	Homo sapiens	% Control	%	80.0
Not Active	23339204	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23339672	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	78.0	CHEMBL4597	Homo sapiens	% Control	%	78.0
Not Active	23340309	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	94.0	CHEMBL4597	Homo sapiens	% Control	%	94.0
Not Active	23340777	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23341434	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	91.0	CHEMBL4597	Homo sapiens	% Control	%	91.0
Not Active	23341902	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	84.0	CHEMBL4597	Homo sapiens	% Control	%	84.0
Not Active	23342518	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	88.0	CHEMBL4597	Homo sapiens	% Control	%	88.0
Not Active	23342986	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23343616	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	75.0	CHEMBL4597	Homo sapiens	% Control	%	75.0
Not Active	23344084	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	93.0	CHEMBL4597	Homo sapiens	% Control	%	93.0
Not Active	23344722	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	98.0	CHEMBL4597	Homo sapiens	% Control	%	98.0
Not Active	23345295	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	79.0	CHEMBL4597	Homo sapiens	% Control	%	79.0
Not Active	23345763	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	83.0	CHEMBL4597	Homo sapiens	% Control	%	83.0
Not Active	23346340	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23346808	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	93.0	CHEMBL4597	Homo sapiens	% Control	%	93.0
Not Active	23347410	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	82.2	CHEMBL4597	Homo sapiens	% Control	%	82.2
Not Active	23347900	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23348479	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23348947	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	76.0	CHEMBL4597	Homo sapiens	% Control	%	76.0
Not Active	23349534	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	68.0	CHEMBL4597	Homo sapiens	% Control	%	68.0
Not Active	23350152	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	82.0	CHEMBL4597	Homo sapiens	% Control	%	82.0
Not Active	23350620	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	81.0	CHEMBL4597	Homo sapiens	% Control	%	81.0
Not Active	23351225	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	98.0	CHEMBL4597	Homo sapiens	% Control	%	98.0
Not Active	23351693	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	84.0	CHEMBL4597	Homo sapiens	% Control	%	84.0
Not Active	23352717	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	85.0	CHEMBL4597	Homo sapiens	% Control	%	85.0
Not Active	23353185	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	87.0	CHEMBL4597	Homo sapiens	% Control	%	87.0
Not Active	23354067	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23354535	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23355267	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23355735	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23356371	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23356839	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23357448	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23358095	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23358563	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	81.0	CHEMBL4597	Homo sapiens	% Control	%	81.0
Not Active	23359149	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	91.9	CHEMBL4597	Homo sapiens	% Control	%	91.9
Not Active	23359747	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	83.0	CHEMBL4597	Homo sapiens	% Control	%	83.0
Not Active	23360215	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	96.0	CHEMBL4597	Homo sapiens	% Control	%	96.0
Not Active	23360800	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	77.0	CHEMBL4597	Homo sapiens	% Control	%	77.0
Not Active	23361268	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	98.0	CHEMBL4597	Homo sapiens	% Control	%	98.0
Not Active	23361841	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	75.0	CHEMBL4597	Homo sapiens	% Control	%	75.0
Not Active	23362377	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23362845	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23364487	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	61.0	CHEMBL4597	Homo sapiens	% Control	%	61.0
Not Active	23364955	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	67.0	CHEMBL4597	Homo sapiens	% Control	%	67.0
Not Active	23365694	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23366237	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23366827	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	97.0	CHEMBL4597	Homo sapiens	% Control	%	97.0
Not Active	23367295	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23367689	CHEMBL4884042	PCTAIRE1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	79.0	CHEMBL4597	Homo sapiens	% Residual activity with Skepinone-L	%	79.0
Not Active	23368173	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	75.0	CHEMBL4597	Homo sapiens	% Control	%	75.0
Not Active	23368641	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	65.0	CHEMBL4597	Homo sapiens	% Control	%	65.0
Not Active	23369240	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23369708	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	74.0	CHEMBL4597	Homo sapiens	% Control	%	74.0
Not Active	23370676	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23371144	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	93.0	CHEMBL4597	Homo sapiens	% Control	%	93.0
Not Active	23371953	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23372421	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
	23372685	CHEMBL4884650	PCTAIRE1(CD16SGS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4597	Homo sapiens	pIC50		6.0
	23373094	CHEMBL4884941	PCTAIRE1(CD16SGS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4597	Homo sapiens	pIC50		6.0
	23373455	CHEMBL4885232	PCTAIRE1(CD16SGS1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4597	Homo sapiens	pIC50		6.0
Not Active	23375848	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	88.0	CHEMBL4597	Homo sapiens	% Control	%	88.0
Not Active	23376316	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23376893	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23377361	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23378221	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	75.0	CHEMBL4597	Homo sapiens	% Control	%	75.0
Not Active	23378689	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	83.0	CHEMBL4597	Homo sapiens	% Control	%	83.0
Not Active	23379856	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	67.0	CHEMBL4597	Homo sapiens	% Control	%	67.0
Not Active	23380324	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23381018	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23381666	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4597	Homo sapiens	% Control	%	100.0
Not Active	23382134	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	97.0	CHEMBL4597	Homo sapiens	% Control	%	97.0
Not Active	23382758	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	99.0	CHEMBL4597	Homo sapiens	% Control	%	99.0
Not Active	23383226	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	82.0	CHEMBL4597	Homo sapiens	% Control	%	82.0
Not Active	23383593	CHEMBL4887253	CDK16 (PCTK1)/CYC Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL4597	Homo sapiens	% Ctrl	%	87.0
Not Active	23385141	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	66.0	CHEMBL4597	Homo sapiens	% Control	%	66.0
Not Active	23385608	CHEMBL4879865	KinomeScan assay: inhibition of PCTK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	72.0	CHEMBL4597	Homo sapiens	% Control	%	72.0
